Mangalam Drugs and Organics shareholders and shareholding pattern
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Last close ₹28.65down ₹0.92 (3.11%)BSE ₹28.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.
52-week range of traded prices to 23 Oct 2026
₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,55176.4% delivered
Who owns Mangalam Drugs and Organics, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters35.65%
- Foreign institutions0.11%
- Indian institutionsNone
- Individuals and others64.24%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 19 Jan | Mar 2017Filed 7 Apr | Jun 2017Filed 14 Jul | Sep 2017Filed 13 Oct | Dec 2017Filed 16 Jan | Mar 2018Filed 19 Apr | Jun 2018Filed 13 Jul | Sep 2018Filed 5 Oct | Dec 2018Filed 7 Jan | Mar 2019Filed 9 Apr | Jun 2019Filed 20 Jul | Sep 2019Filed 4 Nov | Dec 2019Filed 24 Jan | Mar 2020Filed 16 May | Jun 2020Filed 16 Jul | Sep 2020Filed 20 Oct | Dec 2020Filed 9 Jan | Mar 2021Filed 14 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 8 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 16 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 17 Jan | Mar 2023Filed 18 Apr | Jun 2023Filed 20 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 19 Apr | Jun 2024Filed 9 Jul | Sep 2024Filed 15 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 19 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 10 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.76% | 50.76% | 50.76% | 50.76% | 50.76% | 50.76% | 50.13% | 50.60% | 50.53% | 49.27% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.42% | 50.42% | 50.32% | 50.32% | 50.32% | 50.32% | 50.32% | 50.32% | 50.32% | 50.30% | 50.30% | 50.30% | 50.30% | 50.30% | 35.64% | 35.65% | 35.65% | 35.65% | |
| Indian promoters | 50.76% | 50.76% | 50.76% | 50.76% | 50.76% | 50.76% | 50.13% | 50.60% | 50.53% | 49.27% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.53% | 50.42% | 50.42% | 50.32% | 50.32% | 50.32% | 50.32% | 50.32% | 50.32% | 50.32% | 50.30% | 50.30% | 50.30% | 50.30% | 50.30% | 35.64% | 35.65% | 35.65% | 35.65% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 49.24% | 49.24% | 49.24% | 49.24% | 49.24% | 49.24% | 49.87% | 49.40% | 49.47% | 50.73% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.47% | 49.58% | 49.58% | 49.68% | 49.68% | 49.68% | 49.68% | 49.68% | 49.68% | 49.68% | 49.70% | 49.70% | 49.70% | 49.70% | 49.70% | 64.36% | 64.35% | 64.35% | 64.35% |
| Promoter shares pledgedShare of the promoters' own shares | 50.41% | 50.41% | 50.41% | 50.41% | 42.78% | 11.65% | 19.25% | 23.52% | 24.94% | 26.57% | 0.00% | 0.00% | 0.00% | 61.89% | 61.89% | 33.57% | 33.57% | 33.57% | 33.57% | 11.59% | 16.88% | 19.98% | 16.97% | 16.22% | 16.65% | 20.93% | 20.04% | 17.52% | 18.08% | 17.58% | 14.88% | 10.26% | 11.01% | 13.23% | 13.23% | 34.58% | 7.09% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 | 1,58,28,248 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 14,50,000 | 14,50,000 | – | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Promoters' shares locked in | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 26,50,000 | 14,50,000 | 14,50,000 | – | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Mangalam Drugs and Organics promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Shree Rasbihari Trading & Investment Pvt Ltd, 6.21%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Shree Rasbihari Trading & Investment Pvt LtdIndian companies, trusts and others | 6.21% | 9,82,563 |
| Shri Jb Pharma Private LimitedIndian companies, trusts and others | 6.00% | 9,50,000 |
| Govardhan Murlidhar DhootIndividuals and Hindu undivided families | 4.21% | 6,67,189 |
| Brijmohan Murlidhar DhootIndividuals and Hindu undivided families | 3.57% | 5,64,469 |
| Shree Kishoriju Trading & Investment Pvt LtdIndian companies, trusts and others | 3.21% | 5,08,599 |
| Shweta Govardhan DhootIndividuals and Hindu undivided families | 2.59% | 4,10,000 |
| Smita Aditya DhootIndividuals and Hindu undivided families | 1.85% | 2,92,500 |
| Radhika Ajay DhootIndividuals and Hindu undivided families | 1.85% | 2,92,500 |
| Ramniwas Ramdayal DhootIndividuals and Hindu undivided families | 1.74% | 2,75,948 |
| Raj Exports Pvt LtdIndian companies, trusts and others | 1.21% | 1,91,520 |
| Rekha Govardhan DhootIndividuals and Hindu undivided families | 0.93% | 1,46,760 |
| Ajay Ramniwas DhootIndividuals and Hindu undivided families | 0.88% | 1,38,687 |
No promoter shares are reported as pledged.
Largest public holders of Mangalam Drugs and Organics, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 19 Jan | Mar 2017Filed 7 Apr | Jun 2017Filed 14 Jul | Sep 2017Filed 13 Oct | Dec 2017Filed 16 Jan | Mar 2018Filed 19 Apr | Jun 2018Filed 13 Jul | Sep 2018Filed 5 Oct | Dec 2018Filed 7 Jan | Mar 2019Filed 9 Apr | Jun 2019Filed 20 Jul | Sep 2019Filed 4 Nov | Dec 2019Filed 24 Jan | Mar 2020Filed 16 May | Jun 2020Filed 16 Jul | Sep 2020Filed 20 Oct | Dec 2020Filed 9 Jan | Mar 2021Filed 14 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 8 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 16 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 17 Jan | Mar 2023Filed 18 Apr | Jun 2023Filed 20 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 19 Apr | Jun 2024Filed 9 Jul | Sep 2024Filed 15 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 19 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 10 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anish DwivediResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | 1.42% |
| Thakkalapalli Sampath RaoResident individuals, over ₹2 lakh at face value | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | 1.04% | – | 1.03% | 1.03% | 1.03% |
| Ambika Food Industries Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | – | – | – |
| Ashutosh TapariaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | 1.91% | – | 1.91% | 1.91% | – | – | – | – |
| Jyotiprasad TapariaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.19% | 1.19% | 1.19% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | 1.33% | – | – | – | – |
| Ashutosh TapriaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.91% | – | – | – | – | – | – |
| Ajay UpadhyayaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.26% | 1.90% | 1.90% | 1.90% | 1.90% | 1.90% | 1.90% | – | – | – | – | – | – | – | – | – | – | – | – |
| Sanjeevkumar TapariaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.54% | 1.90% | 1.90% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Sicom LimitedFinancial Institution Or Banks | – | – | – | – | – | – | – | – | – | 1.26% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.